Tricyclic Carboxamide Derivatives as PRMT5 Inhibitors for Treating Cancer.
作者信息
Sabnis Ram W
机构信息
Smith, Gambrell & Russell LLP, 1105 West Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
出版信息
ACS Med Chem Lett. 2022 Jul 12;13(8):1204-1205. doi: 10.1021/acsmedchemlett.2c00292. eCollection 2022 Aug 11.
Abstract
摘要
相似文献
1
Tricyclic Carboxamide Derivatives as PRMT5 Inhibitors for Treating Cancer.作为用于治疗癌症的PRMT5抑制剂的三环甲酰胺衍生物
ACS Med Chem Lett. 2022 Jul 12;13(8):1204-1205. doi: 10.1021/acsmedchemlett.2c00292. eCollection 2022 Aug 11.
2
Discovery of 2-substituted-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxamide as potent and selective protein arginine methyltransferases 5 inhibitors: Design, synthesis and biological evaluation.发现 2-取代-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)-1,2,3,4-四氢异喹啉-6-甲酰胺作为有效的和选择性的蛋白质精氨酸甲基转移酶 5 抑制剂：设计、合成和生物评价。
Eur J Med Chem. 2019 Feb 15;164:317-333. doi: 10.1016/j.ejmech.2018.12.065. Epub 2018 Dec 26.
3
Structure-activity relationship study of a series of nucleoside derivatives bearing sulfonamide scaffold as potent and selective PRMT5 inhibitors.带有磺酰胺支架的一系列核苷衍生物作为有效和选择性的 PRMT5 抑制剂的构效关系研究。
Bioorg Chem. 2023 Jan;130:106228. doi: 10.1016/j.bioorg.2022.106228. Epub 2022 Nov 4.
4
A patent review of PRMT5 inhibitors to treat cancer (2018 - present).PRMT5 抑制剂治疗癌症的专利审查（2018 年至今）。
Expert Opin Ther Pat. 2023 Apr;33(4):265-292. doi: 10.1080/13543776.2023.2201436. Epub 2023 Apr 27.
5
Discovery of tetrahydroisoquinolineindole derivatives as first dual PRMT5 inhibitors/hnRNP E1 upregulators: Design, synthesis and biological evaluation.四氢异喹啉吲哚衍生物作为首个双重 PRMT5 抑制剂/hnRNP E1 上调剂的发现：设计、合成与生物评价。
Eur J Med Chem. 2023 Oct 5;258:115625. doi: 10.1016/j.ejmech.2023.115625. Epub 2023 Jul 5.
6
Arginine Methyltransferase 5 (PRMT5) Inhibitors with 3-(1H-benzo[d]imidazol- 2-yl)anilines Core Identified by Virtual Screening and Biological Evaluation.通过虚拟筛选和生物评估鉴定的具有 3-(1H-苯并[d]咪唑-2-基)苯胺核心的精氨酸甲基转移酶 5 (PRMT5)抑制剂。
Curr Pharm Des. 2023;29(6):474-479. doi: 10.2174/1381612829666230215105046.
7
Discovery of novel PRMT5 inhibitors bearing a methylpiperazinyl moiety.发现具有甲基哌嗪基部分的新型 PRMT5 抑制剂。
Future Med Chem. 2022 Jul;14(14):1071-1086. doi: 10.4155/fmc-2021-0244. Epub 2022 Jun 24.
8
The Role of the PRMT5-SND1 Axis in Hepatocellular Carcinoma.PRMT5-SND1轴在肝细胞癌中的作用
Epigenomes. 2021 Mar;5(1). doi: 10.3390/epigenomes5010002. Epub 2021 Jan 5.
9
Medicinal chemistry strategies targeting PRMT5 for cancer therapy.针对PRMT5的癌症治疗药物化学策略。
Eur J Med Chem. 2022 Dec 15;244:114842. doi: 10.1016/j.ejmech.2022.114842. Epub 2022 Oct 14.
10
PRMT5/FGFR3/AKT Signaling Axis Facilitates Lung Cancer Cell Metastasis.PRMT5/FGFR3/AKT 信号轴促进肺癌细胞转移。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231161139. doi: 10.1177/15330338231161139.
引用本文的文献
1
Virtual Special Issue: Epigenetics 2022.虚拟特刊：2022年表观遗传学
ACS Pharmacol Transl Sci. 2022 Sep 9;5(10):829-834. doi: 10.1021/acsptsci.2c00169. eCollection 2022 Oct 14.
2
Virtual Special Issue: Epigenetics 2022.虚拟特刊：2022年表观遗传学
ACS Med Chem Lett. 2022 Oct 13;13(10):1524-1529. doi: 10.1021/acsmedchemlett.2c00393.
本文引用的文献
1
Protein arginine N-methyltransferase 5 in colorectal carcinoma: Insights into mechanisms of pathogenesis and therapeutic strategies.蛋白质精氨酸 N-甲基转移酶 5 在结直肠癌中的作用：发病机制和治疗策略的新见解。
Biomed Pharmacother. 2022 Jan;145:112368. doi: 10.1016/j.biopha.2021.112368. Epub 2021 Nov 15.
2
PRMT5: An Emerging Target for Pancreatic Adenocarcinoma.蛋白精氨酸甲基转移酶5：胰腺腺癌的一个新靶点
Cancers (Basel). 2021 Oct 13;13(20):5136. doi: 10.3390/cancers13205136.
3
Systemic therapies for salivary gland adenoid cystic carcinoma.涎腺腺样囊性癌的全身治疗
Am J Cancer Res. 2021 Sep 15;11(9):4092-4110. eCollection 2021.
4
Protein arginine methyltransferases and hepatocellular carcinoma: A review.蛋白质精氨酸甲基转移酶与肝细胞癌：综述
Transl Oncol. 2021 Nov;14(11):101194. doi: 10.1016/j.tranon.2021.101194. Epub 2021 Aug 5.
5
Coordinated methyl readers: Functional communications in cancer.协调的甲基读取器：癌症中的功能通讯。
Semin Cancer Biol. 2022 Aug;83:88-99. doi: 10.1016/j.semcancer.2021.03.015. Epub 2021 Mar 19.
6
New insights into molecules and pathways of cancer metabolism and therapeutic implications.癌症代谢的分子和途径的新见解及其治疗意义。
Cancer Commun (Lond). 2021 Jan;41(1):16-36. doi: 10.1002/cac2.12112. Epub 2020 Nov 10.
Zotero 插件